“These are my losses that no one has compensated”: Small pharmacies are suffering from the revaluation of the TOP 100 drugs

The revaluation of drugs included in the list of TOP-100 drugs, the prices of which were to decrease by 30% from March 1, has significantly hit small pharmacies, especially in the front-line regions. This was stated in an exclusive comment to UNN by Larysa Homan, the owner of several pharmacy outlets in Kherson and Mykolaiv. 

To be honest, I have enough problems as it is: everything is being destroyed, there are no deliveries. And this resolution… We reduced the price of medicines and suffered losses, because even the same Gidazepam now costs almost as much in sales as it did in purchase. There was also a big difference with Fanigan, drops from “Farmak”, pharmazolin. These are my losses, which no one compensated. Everything fell on me,” she said.

According to her, although her pharmacies had small stocks, the revaluation resulted in a “big penny.”

I had four pharmacies in Kherson, but now I only bring the essentials there – dressing, alcohol, bandages. And there is one in Mykolaiv, but it is small,” Larysa Homan said.

The entrepreneur added that it has become much harder to work now, and the financial burden on small pharmacy businesses is increasing.

There will be no savings for the residents of the village, as they will have to go to the city for medicines: the owner of pharmacies in Mykolaiv region on the new regulation of the pharmaceutical market. 28.03.25, 11:26 • 167083 views

Let us remind youResolution of the Cabinet of Ministers of Ukraine No. 168 of February 14, 2025 provides new rules for regulating the pharmaceutical market. In particular, restrictions were introduced on markups on supply and marketing and retail allowances for all medicines, not only for certain categories. In addition, the resolution prohibits retailers from entering into marketing agreements with pharmaceutical manufacturers that allowed pharmacies to provide discounts for patients, implement social projects and train pharmacists.

The purpose of the resolution was to reduce the prices of medicines and increase their accessibility to the population. At the same time, patient organizations warned that excessive regulation could lead to a shortage of medicines, the closure of pharmacies in small towns and villages, and the termination of social programs to support patients.

As UNN was informed in the State Regulatory Service, despite the fact that this CMU resolution is regulatory, it did not undergo their expertise. They stressed that this is a violation of the Law on Regulatory Policy.